• Explore /
  • Poster
  • / Safety and clinical activity of MK-3475 in previously treated patients (pts) with non-small cell lung cancer (NSCLC).

Safety and clinical activity of MK-3475 in previously treated patients (pts) with non-small cell lung cancer (NSCLC).

Abstract Poster

Authors

null

Edward B. Garon

University of California, Los Angeles, Los Angeles, CA

Edward B. Garon , Natasha B. Leighl , Naiyer A. Rizvi , George R. Blumenschein Jr., Ani Sarkis Balmanoukian , Joseph Paul Eder , Jonathan Wade Goldman , Rina Hui , Jean-Charles Soria , Tara C. Gangadhar , Jong-Mu Sun , Amita Patnaik , Matthew A. Gubens , Gregory M. Lubiniecki , Jin Zhang , Michelle Niewood , Kenneth Emancipator , Marisa Dolled-Filhart , Mary Elizabeth Hanson , Leena Gandhi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Highlights Session

Session Title

Lung Cancer - Non-small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT01295827

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 8020)

DOI

10.1200/jco.2014.32.15_suppl.8020

Abstract #

8020

Poster Bd #

34

Abstract Disclosures

Similar Posters

First Author: Thierry Landre

First Author: Ani Sarkis Balmanoukian

First Author: Saveri Bhattacharya

First Author: Melissa Lynne Johnson